INS and atherosclerosis: In addition, genetic deletion of MMP12 ameliorates cardiometabolic diseases by reducing circulating lipid levels, obesity-induced low-grade inflammation, WAT dysfunction, insulin sensitivity, and atherosclerosis in a room temperature-housed cardiometabolic mouse model (24).